GANX · Categories · Form 4
GANX - SEC Form 4 insider transactions
Gain Therapeutics Inc. (GANX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for GANX
- SEC Form 4 filed by Mack Gene4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Fuggetta Gianluca4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Director Islam Khalid4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Director Richman Eric I4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Director Nicaise Claude4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Director Hasler Hans Peter4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Director Riley Jeffrey Scott4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Director Goldstein Dov A Md4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Director Melincoff Gwen A4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by See Remark Fuggetta Gianluca4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by CEO, President Mack Gene4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by CEO, President Mack Gene4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Director Islam Khalid4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Director Hasler Hans Peter4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Director Melincoff Gwen A4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Director Nicaise Claude4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Director Goldstein Dov A Md4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Director Riley Jeffrey Scott4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Director Richman Eric I4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Mack Gene4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- Alder Matthias covered exercise/tax liability with 6,085 shares and converted options into 20,212 shares, increasing direct ownership by 201% to 21,140 units (SEC Form 4)4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Fuggetta Gianluca4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Alder Matthias4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- Alder Matthias converted options into 637 shares and sold $507 worth of shares (206 units at $2.46), increasing direct ownership by 9% to 5,286 units (SEC Form 4)4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- Alder Matthias sold $4,550 worth of shares (1,820 units at $2.50), decreasing direct ownership by 27% to 4,855 units (SEC Form 4)4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- Alder Matthias converted options into 825 shares, increasing direct ownership by 14% to 6,675 units (SEC Form 4)4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4: Richman Eric I converted options into 54,900 shares, increasing direct ownership by 25% to 272,629 units4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4: Alder Matthias converted options into 2,550 shares, increasing direct ownership by 77% to 5,850 units4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Alder Matthias4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Islam Khalid4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Riley Jeffrey Scott4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Goldstein Dov A Md4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Melincoff Gwen A4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Nicaise Claude4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Hasler Hans Peter4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Ballantyne Charles Evan4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Calabrese Salvatore4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Fuggetta Gianluca4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Alder Matthias4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Richman Eric I4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Islam Khalid4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Riley Jeffrey Scott4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Goldstein Dov A Md4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Melincoff Gwen A4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Nicaise Claude4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Hasler Hans Peter4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Alder Matthias4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Calabrese Salvatore4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Alder Matthias4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4: Richman Eric I bought $6,404 worth of shares (2,482 units at $2.58), increasing direct ownership by 1% to 217,729 units4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4: Richman Eric I bought $10,840 worth of shares (4,000 units at $2.71) and bought $26,194 worth of shares (9,256 units at $2.83), increasing direct ownership by 7% to 215,247 units4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4: Calabrese Salvatore bought $8,100 worth of shares (3,000 units at $2.70) (Amendment)4/A - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4: Calabrese Salvatore bought $24,300,000 worth of shares (3,000 units at $8,100.00), increasing direct ownership by 59% to 8,100 units4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4: Richman Eric I bought $38,716 worth of shares (4,922 units at $7.87), increasing direct ownership by 2% to 216,820 units (Amendment)4/A - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4 filed by Alder Matthias4 - Gain Therapeutics, Inc. (0001819411) (Issuer)
- SEC Form 4: RICHMAN ERIC I exercised 4,922 units of Common Stock at a strike of $7.87, increasing direct ownership by 2% to 216,820 units4 - Gain Therapeutics, Inc. (0001819411) (Issuer)